| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,755 |
1,473 |
$50K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
273 |
246 |
$11K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
49 |
48 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
85 |
80 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
207 |
194 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
122 |
116 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
40 |
37 |
$628.69 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
46 |
46 |
$542.47 |
| 86328 |
|
15 |
15 |
$528.22 |
| 96127 |
|
48 |
44 |
$113.56 |
| 1126F |
|
126 |
118 |
$0.29 |
| 1125F |
|
57 |
56 |
$0.16 |
| 888888 |
|
78 |
66 |
$0.00 |
| 1159F |
|
198 |
189 |
$0.00 |
| 99072 |
|
367 |
311 |
$0.00 |
| 1160F |
|
197 |
189 |
$0.00 |